7, Mantle Novel, Finds a Publisher [NYT]
Even Bitches Have Feelings [NYM]
A Second Life for Regan’s ‘7’
coronavirus
Can Businesses Require Masks After States Lift Their Mandates?
7, Mantle Novel, Finds a Publisher [NYT]
Even Bitches Have Feelings [NYM]
The head of the D.C. National Guard testified that if not for “unusual” Pentagon restrictions on January 6, he could have had 150 soldiers at the Capitol in 20 minutes
The commanding general of the D.C. National Guard told lawmakers Wednesday how restrictions the Pentagon placed on him in the run-up to the Capitol riot prevented him from more quickly sending forces to help quell the violence.
Maj. Gen. William J. Walker said he did not receive approval to change the D.C. Guard’s mission and send his forces to the Capitol on Jan. 6 until three hours and 19 minutes after he first received an emotional call from the Capitol Police chief requesting urgent backup.
Walker described the Pentagon’s restrictions as “unusual,” noting that he did not have such limitations last summer, when the D.C. Guard was tasked with responding to local racial-justice protests after the killing of George Floyd.
How Capitol Police are preparing for Trump’s fake inauguration day
The United States Capitol Police said it has beefed up security on Capitol Hill this week due to “concerning information and intelligence” related to March 4, the date that far-right conspiracy theorists believe former President Donald Trump will return to power.
“The Department is aware of concerning information and intelligence pertaining March 4th and continues to work with all of our law enforcement partners,” the federal law enforcement agency said in a statement Tuesday night. “Based on the intelligence that we have, the Department has taken immediate steps to enhance our security posture and staffing for a number of days, to include March 4th. The Department has communicated our enhanced posture as well as the available intelligence for the entire workforce.”
Vernon Jordan, civil rights leader and Washington power broker, has died at 85
Vernon E. Jordan Jr. never held elective office, was never a member of the Cabinet and never even worked for the federal government. He was a lawyer who rarely appeared in court, a corporate kingmaker who was not a registered lobbyist, a political strategist who did not direct a campaign.
Yet Mr. Jordan was, for years, one of the most influential figures in Washington. With a commanding presence, personal charm and an inviolable sense of discretion, he had a rare combination of talents that made him the confidant of presidents, congressional leaders, business executives and civil rights figures.
Mr. Jordan was the consummate Washington power broker, reaching the peak of his quiet authority during the 1990s, when he was, with the possible exception of Hillary Clinton, President Bill Clinton’s closest adviser. He had Clinton’s ear through two terms as president, including the most challenging moments, when Clinton faced an investigation and impeachment for a relationship with a White House intern.
“The last thing he’d ever do is betray a friendship,” Clinton said in 1996. “It’s good to have a friend like that.”
Mr. Jordan died March 1 at his home in Washington. He was 85. The death was confirmed by his daughter, Vickee Jordan. She declined to state the cause.
Biden will use the Defense Production Act to help dramatically increase Johnson & Johnson vaccine production
President Biden will announce Tuesday that pharmaceutical giant Merck & Co. will help make Johnson & Johnson’s single-shot coronavirus vaccine — an unusual pact between fierce competitors that could sharply boost the supply of the newly authorized vaccine, according to senior administration officials.
The officials, who spoke on the condition of anonymity to discuss a matter that has not been announced, said they began scouring the country for additional manufacturing capacity after they realized in the first days of the administration that Johnson & Johnson had fallen behind in vaccine production. They soon sought to broker a deal with Merck, one of the world’s largest vaccine makers, which had tried and failed to develop its own coronavirus vaccine.
Under the arrangement, Merck will dedicate two facilities in the United States to Johnson & Johnson’s shots. One will provide “fill-finish” services, the last stage of the production process during which the vaccine substance is placed in vials and packaged for distribution. The other will make the vaccine itself, and has the potential to vastly increase supply, perhaps even doubling what Johnson & Johnson could make on its own, the officials said.
Already a subscriber? Log in or link your magazine subscription
Already a subscriber? Log in or link your magazine subscription
Already a subscriber? Log in or link your magazine subscription
Already a subscriber? Log in or link your magazine subscription
Already a subscriber? Log in or link your magazine subscription